Stockscreener 앱 받기
5.29
1.34%
0.07
시간 외 거래:
5.28
-0.010
-0.19%
전일 마감가:
$5.22
열려 있는:
$5.26
하루 거래량:
347.74K
Relative Volume:
1.86
시가총액:
$201.22M
수익:
$239.40M
순이익/손실:
$104.44M
주가수익비율:
1.7872
EPS:
2.96
순현금흐름:
$-18.50M
1주 성능:
-3.29%
1개월 성능:
-9.26%
6개월 성능:
-50.00%
1년 성능:
-65.63%
1일 변동 폭
$5.21
$5.525
1주일 범위
$5.17
$5.6556
52주 변동 폭
$4.93
$21.79
Entrada Therapeutics Inc Stock (TRDA) Company Profile
명칭
Entrada Therapeutics Inc
전화
857-305-1825
주소
ONE DESIGN CENTER PLACE, BOSTON
TRDA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TRDA
Entrada Therapeutics Inc
|
5.29 | 198.55M | 239.40M | 104.44M | -18.50M | 2.96 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Entrada Therapeutics Inc Stock (TRDA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-06 | 개시 | ROTH MKM | Buy |
| 2024-01-05 | 개시 | Oppenheimer | Outperform |
| 2023-04-03 | 개시 | H.C. Wainwright | Buy |
Entrada Therapeutics Inc 주식(TRDA)의 최신 뉴스
Is Entrada Therapeutics Inc. currently under institutional pressureMarket Trend Review & Growth Focused Entry Point Reports - خودرو بانک
American Century Companies Inc. Boosts Stock Holdings in Entrada Therapeutics, Inc. $TRDA - Defense World
Entrada Therapeutics’ DREAMS Grant Program: A Strategic Catalyst for Patient-Centric Innovation and Stakeholder Trust - AInvest
Entrada Therapeutics Inc. stock trend outlook and recovery pathMarket Volume Summary & Real-Time Buy Zone Alerts - Newser
Can Entrada Therapeutics Inc. deliver consistent dividendsJuly 2025 Selloffs & Advanced Swing Trade Entry Alerts - خودرو بانک
What analysts say about Entrada Therapeutics Inc. stockEarnings Beat & Detailed Earnings Play Alerts - خودرو بانک
Is Entrada Therapeutics Inc. a top pick in the sector2025 Buyback Activity & AI Enhanced Trade Execution Alerts - خودرو بانک
Is Entrada Therapeutics Inc. stock a good dividend stockPortfolio Value Report & Entry Point Strategy Guides - خودرو بانک
Can machine learning forecast Entrada Therapeutics Inc. recoveryMarket Sentiment Summary & Fast Momentum Stock Entry Tips - Newser
Automated trading signals detected on Entrada Therapeutics Inc.Quarterly Performance Summary & AI Driven Price Forecasts - Newser
Can Entrada Therapeutics Inc. ride the EV waveTrade Signal Summary & Verified Momentum Stock Alerts - خودرو بانک
Candlestick signals on Entrada Therapeutics Inc. stock today2025 Key Highlights & High Accuracy Buy Signal Tips - Newser
Entrada Therapeutics Announces Recipients of Third Annual DREAMS Grant Program - The Manila Times
$50K Each: Two Non-Profits Win Entrada's DREAMS Grants for Revolutionary Duchenne Care Programs - Stock Titan
Institutional scanner results for Entrada Therapeutics Inc.2025 Trading Recap & Consistent Growth Stock Picks - Newser
Can Entrada Therapeutics Inc. rally from current levels2025 Buyback Activity & Daily Profit Focused Screening - Newser
Regression analysis insights on Entrada Therapeutics Inc. performanceMarket Performance Summary & Growth Focused Entry Reports - Newser
Is Entrada Therapeutics Inc. stock ready for a breakoutPrice Action & Daily Oversold Stock Bounce Ideas - Newser
Will Entrada Therapeutics Inc. see short term momentumQuarterly Earnings Summary & Capital Efficient Trading Techniques - Newser
Can a trend reversal in Entrada Therapeutics Inc. lead to recoveryPrice Action & Risk Managed Investment Signals - Newser
Historical volatility pattern of Entrada Therapeutics Inc. visualizedJuly 2025 Fed Impact & Expert Approved Momentum Trade Ideas - Newser
What’s the MACD signal for Entrada Therapeutics Inc.July 2025 Momentum & Low Risk High Win Rate Stock Picks - خودرو بانک
Tools to assess Entrada Therapeutics Inc.’s risk profilePortfolio Gains Report & Comprehensive Market Scan Reports - Newser
Measuring Entrada Therapeutics Inc.’s beta against major indicesQuarterly Portfolio Report & Smart Money Movement Alerts - Newser
Applying chart zones and confluence areas to Entrada Therapeutics Inc.Weekly Trend Recap & High Conviction Buy Zone Alerts - Newser
What MACD and RSI say about Entrada Therapeutics Inc.2025 Top Decliners & Community Verified Trade Alerts - Newser
Using R and stats models for Entrada Therapeutics Inc. forecastingIPO Watch & Weekly High Return Opportunities - Newser
Detecting support and resistance levels for Entrada Therapeutics Inc.July 2025 EndofMonth & Reliable Volume Spike Alerts - Newser
What MACD and RSI say about Entrada Therapeutics IncJuly 2025 Reactions & Real-Time Stock Movement Alerts - Newser
Real time social sentiment graph for Entrada Therapeutics Inc.Quarterly Portfolio Report & Trade Opportunity Analysis - Newser
How to recover losses in Entrada Therapeutics Inc. stockJuly 2025 Review & Safe Capital Investment Plans - Newser
Momentum divergence signals in Entrada Therapeutics Inc. chartQuarterly Market Review & Weekly Top Gainers Trade List - Newser
Strategic Equity Incentives and Talent Retention in High-Growth Biotech - AInvest
Entrada Therapeutics announces inducement grants under Nasdaq listing rule 5635(c)(4) - MarketScreener
Entrada Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Globe and Mail
93,210 Shares: Entrada Therapeutics Issues Major Equity Compensation Package to New Hires at $5.47 - Stock Titan
What earnings revisions data tells us about Entrada Therapeutics Inc.Earnings Risk Report & Advanced Technical Signal Analysis - Newser
Is Entrada Therapeutics Inc. subject to activist investor interestWall Street Watch & Weekly High Conviction Trade Ideas - خودرو بانک
Will Entrada Therapeutics Inc. benefit from rising consumer demandEarnings Risk Report & Growth Focused Stock Pick Reports - خودرو بانک
Exit strategy if you’re trapped in Entrada Therapeutics Inc.Insider Selling & Accurate Buy Signal Alerts - Newser
Is a relief rally coming for Entrada Therapeutics Inc. holdersGap Down & Long-Term Investment Growth Plans - Newser
Can Entrada Therapeutics Inc. disrupt its industryEarnings Recap Report & Growth-Oriented Investment Plans - خودرو بانک
Is Entrada Therapeutics Inc. showing insider buying2025 Earnings Surprises & Daily Stock Momentum Reports - خودرو بانک
Will Entrada Therapeutics Inc. benefit from rate cutsM&A Rumor & High Win Rate Trade Alerts - خودرو بانک
Short interest data insights for Entrada Therapeutics Inc.2025 Trading Volume Trends & Comprehensive Market Scan Insights - Newser
Entrada Therapeutics Inc (TRDA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Entrada Therapeutics Inc 주식 (TRDA) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| 5AM Ventures V, L.P. | 10% Owner |
Jul 09 '25 |
Sale |
7.50 |
20,065 |
150,528 |
3,163,066 |
| 5AM Ventures V, L.P. | 10% Owner |
Jul 09 '25 |
Sale |
7.50 |
6,935 |
52,026 |
1,093,313 |
1.40%
자본화:
|
볼륨(24시간):